c-Rel promotes type 1 and type 17 immune responses during Leishmania major infection

European Journal of Immunology

Volumn 41, Issue 5, 2011, Pages 1388-1398

  Reinhard, Katharina ^a   Huber, Magdalena ^a   Wostl, Corinna ^a   Hellhund, Anne ^a   Toboldt, Anne ^a   Abass, Elfadil ^a   Casper, Bärbel ^a   Joeris, Thorsten ^b   Herr, Christian ^c   Bals, Robert ^c   Steinhoff, Ulrich ^a,b   Lohoff, Michael ^a   Visekruna, Alexander ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

^b MAX PLANCK INSTITUTE FOR INFECTION BIOLOGY   (Germany)

^c SAARLAND UNIVERSITY   (Germany)

Author keywords

C Rel; IL 12; Leishmania major; Myeloid cells; Th1

Indexed keywords

INTERLEUKIN 12P40; INTERLEUKIN 17; INTERLEUKIN 23; RECOMBINANT INTERLEUKIN 12; TRANSCRIPTION FACTOR REL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL DIFFERENTIATION; CELL POLARITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; IMMUNE RESPONSE; LEISHMANIA MAJOR; LEISHMANIASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; TH1 CELL; TH17 CELL;

ANIMALS; CELL DIFFERENTIATION; HOMEODOMAIN PROTEINS; INTERFERON-GAMMA; INTERLEUKIN-12; INTERLEUKIN-17; INTERLEUKIN-23; LEISHMANIA MAJOR; LEISHMANIASIS, CUTANEOUS; MACROPHAGES; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; PROTO-ONCOGENE PROTEINS C-REL; T-LYMPHOCYTES, REGULATORY; TH1 CELLS; TH17 CELLS;

EID: 79955159574     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201041056     Document Type: Article

References (50)

1. Vallabhapurapu, S. and Karin, M., Regulation and function of NF-kappaB transcription factors in the immune system. Annu. Rev. Immunol. 2009. 27: 693-733.
2. Bonizzi, G. and Karin, M., The two NF-kappaB activation pathways and their role in innate and adaptive immunity. Trends Immunol. 2004. 25: 280-288.
3. Sun, S. C. and Ley, S. C., New insights into NF-kappaB regulation and function. Trends Immunol. 2008. 29: 469-478.
4. Pasparakis, M., Regulation of tissue homeostasis by NF-kappaB signalling: implications for inflammatory diseases. Nat. Rev. Immunol. 2009. 9: 778-788.
5. Senftleben, U., Cao, Y., Xiao, G., Greten, F. R., Krahn, G., Bonizzi, G., Chen, Y. et al., Activation by IKKalpha of a second, evolutionary conserved, NF-kappa B signaling pathway. Science 2001. 293: 1495-1499.
6. Beinke, S. and Ley, S. C., Functions of NF-kappaB1 and NF-kappaB2 in immune cell biology. Biochem. J. 2004. 382: 393-409.
7. Sacks, D. and Noben-Trauth, N., The immunology of susceptibility and resistance to Leishmania major in mice. Nat. Rev. Immunol. 2002. 2: 845-858.
8. Himmelrich, H., Launois, P., Maillard, I., Biedermann, T., Tacchini-Cottier, F., Locksley, R. M., Rocken, M. and Louis, J. A., In BALB/c mice, IL-4 production during the initial phase of infection with Leishmania major is necessary and sufficient to instruct Th2 cell development resulting in progressive disease. J. Immunol. 2000. 164: 4819-4825.
9. Noben-Trauth, N., Kropf, P. and Muller, I., Susceptibility to Leishmania major infection in interleukin-4-deficient mice. Science 1996. 271: 987-990.
10. Matthews, D. J., Emson, C. L., McKenzie, G. J., Jolin, H. E., Blackwell, J. M. and McKenzie, A. N., IL-13 is a susceptibility factor for Leishmania major infection. J. Immunol. 2000. 164: 1458-1462.
11. Lohoff, M., Ferrick, D., Mittrucker, H. W., Duncan, G. S., Bischof, S., Rollinghoff, M. and Mak, T. W., Interferon regulatory factor-1 is required for a T helper 1 immune response in vivo. Immunity 1997. 6: 681-689.
12. Wang, Z. E., Reiner, S. L., Zheng, S., Dalton, D. K. and Locksley, R. M., CD4+ effector cells default to the Th2 pathway in interferon gamma-deficient mice infected with Leishmania major. J. Exp. Med. 1994. 179: 1367-1371.
13. Mattner, F., Magram, J., Ferrante, J., Launois, P., Di, P. K., Behin, R., Gately, M. K. et al., Genetically resistant mice lacking interleukin-12 are susceptible to infection with Leishmania major and mount a polarized Th2 cell response. Eur. J. Immunol. 1996. 26: 1553-1559.
14. Isomura, I., Palmer, S., Grumont, R. J., Bunting, K., Hoyne, G., Wilkinson, N., Banerjee, A. et al., c-Rel is required for the development of thymic Foxp3+CD4 regulatory T cells. J. Exp. Med. 2009. 206: 3001-3014.
15. Ruan, Q., Kameswaran, V., Tone, Y., Li, L., Liou, H. C., Greene, M. I., Tone, M. and Chen, Y. H., Development of Foxp3(+) regulatory T cells is driven by the c-Rel enhanceosome. Immunity 2009. 31: 932-940.
16. Visekruna, A., Huber, M., Hellhund, A., Bothur, E., Reinhard, K., Bollig, N., Schmidt, N. et al., c-Rel is crucial for the induction of Foxp3(+) regulatory CD4(+) T cells but not T(H)17 cells. Eur. J. Immunol. 2010. 40: 671-676.
17. Belkaid, Y., Piccirillo, C. A., Mendez, S., Shevach, E. M. and Sacks, D. L., CD4+CD25+regulatory T cells control Leishmania major persistence and immunity. Nature 2002. 420: 502-507.
18. Peters, N. and Sacks, D., Immune privilege in sites of chronic infection: Leishmania and regulatory T cells. Immunol. Rev. 2006. 213: 159-179.
19. Suvas, S. and Rouse, B. T., Treg control of antimicrobial T cell responses. Curr. Opin. Immunol. 2006. 18: 344-348.
20. Sanjabi, S., Hoffmann, A., Liou, H. C., Baltimore, D. and Smale, S. T., Selective requirement for c-Rel during IL-12 P40 gene induction in macrophages. Proc. Natl. Acad. Sci. USA 2000. 97: 12705-12710.
21. Grumont, R., Hochrein, H., O'Keeffe, M., Gugasyan, R., White, C., Caminschi, I., Cook, W. and Gerondakis, S., c-Rel regulates interleukin 12 p70 expression in CD8(+) dendritic cells by specifically inducing p35 gene transcription. J. Exp. Med. 2001. 194: 1021-1032.
22. Boffa, D. J., Feng, B., Sharma, V., Dematteo, R., Miller, G., Suthanthiran, M., Nunez, R. and Liou, H. C., Selective loss of c-Rel compromises dendritic cell activation of T lymphocytes. Cell Immunol. 2003. 222: 105-115.
23. Rao, S., Gerondakis, S., Woltring, D. and Shannon, M. F., c-Rel is required for chromatin remodeling across the IL-2 gene promoter. J. Immunol. 2003. 170: 3724-3731.
24. Hilliard, B. A., Mason, N., Xu, L., Sun, J., Lamhamedi-Cherradi, S. E., Liou, H. C., Hunter, C. and Chen, Y. H., Critical roles of c-Rel in autoimmune inflammation and helper T cell differentiation. J. Clin. Invest. 2002. 110: 843-850.
25. Lohoff, M. and Mak, T. W., Roles of interferon-regulatory factors in T-helper-cell differentiation. Nat. Rev. Immunol. 2005. 5: 125-135.
26. Martinez, G. J., Nurieva, R. I., Yang, X. O. and Dong, C., Regulation and function of proinflammatory TH17 cells. Ann. N. Y. Acad. Sci. 2008. 1143: 188-211.
27. Yoshida, Y., Kumar, A., Koyama, Y., Peng, H., Arman, A., Boch, J. A. and Auron, P. E., Interleukin 1 activates STAT3/nuclear factor-kappaB cross-talk via a unique TRAF6 and p65-dependent mechanism. J. Biol. Chem. 2004. 279: 1768-1776.
28. Libermann, T. A. and Baltimore, D., Activation of interleukin-6 gene expression through the NF-kappa B transcription factor. Mol. Cell Biol. 1990. 10: 2327-2334.
29. Mori, N., Shirakawa, F., Shimizu, H., Murakami, S., Oda, S., Yamamoto, K. and Eto, S., Transcriptional regulation of the human interleukin-6 gene promoter in human T-cell leukemia virus type I-infected T-cell lines: evidence for the involvement of NF-kappa B. Blood 1994. 84: 2904-2911.
30. Baeuerle, P. A. and Henkel, T., Function and activation of NF-kappa B in the immune system. Annu. Rev. Immunol. 1994. 12: 141-179.
31. Mise-Omata, S., Kuroda, E., Niikura, J., Yamashita, U., Obata, Y. and Doi, T. S., A proximal kappaB site in the IL-23 p19 promoter is responsible for RelA- and c-Rel-dependent transcription. J. Immunol. 2007. 179: 6596-6603.
32. Wang, Y., Rickman, B. H., Poutahidis, T., Schlieper, K., Jackson, E. A., Erdman, S. E., Fox, J. G. and Horwitz, B. H., c-Rel is essential for the development of innate and T cell-induced colitis. J. Immunol. 2008. 180: 8118-8125.
33. Grigoriadis, G., Zhan, Y., Grumont, R. J., Metcalf, D., Handman, E., Cheers, C. and Gerondakis, S., The Rel subunit of NF-kappaB-like transcription factors is a positive and negative regulator of macrophage gene expression: distinct roles for Rel in different macrophage populations. EMBO J. 1996. 15: 7099-7107.
34. Mason, N. J., Liou, H. C. and Hunter, C. A., T cell-intrinsic expression of c-Rel regulates Th1 cell responses essential for resistance to Toxoplasma gondii. J. Immunol. 2004. 172: 3704-3711.
35. Solbach, W. and Laskay, T., The host response to Leishmania infection. Adv. Immunol. 2000. 74: 275-317.
36. Scharton-Kersten, T., Afonso, L. C., Wysocka, M., Trinchieri, G. and Scott, P., IL-12 is required for natural killer cell activation and subsequent T helper 1 cell development in experimental leishmaniasis. J. Immunol. 1995. 154: 5320-5330.
37. Leon, B., Lopez-Bravo, M. and Ardavin, C., Monocyte-derived dendritic cells formed at the infection site control the induction of protective T helper 1 responses against Leishmania. Immunity. 2007. 26: 519-531.
38. De, T. C., Magez, S., Akira, S., Ryffel, B., Carlier, Y. and Muraille, E., iNOS-producing inflammatory dendritic cells constitute the major infected cell type during the chronic Leishmania major infection phase of C57BL/6 resistant mice. PLoS Pathog. 2009. 5: e1000494.
39. Muraille, E., De, T. C., Brait, M., De, B. P., Leo, O. and Carlier, Y., Genetically resistant mice lacking MyD88-adapter protein display a high susceptibility to Leishmania major infection associated with a polarized Th2 response. J. Immunol. 2003. 170: 4237-4241.
40. Debus, A., Glasner, J., Rollinghoff, M. and Gessner, A., High levels of susceptibility and T helper 2 response in MyD88-deficient mice infected with Leishmania major are interleukin-4 dependent. Infect. Immun. 2003. 71: 7215-7218.
41. de Veer, M. J., Curtis, J. M., Baldwin, T. M., DiDonato, J. A., Sexton, A., McConville, M. J., Handman, E. and Schofield, L., MyD88 is essential for clearance of Leishmania major: possible role for lipophosphoglycan and Toll-like receptor 2 signaling. Eur. J. Immunol. 2003. 33: 2822-2831.
42. Kollet, J. I. and Petro, T. M., IRF-1 and NF-kappaB p50/cRel bind to distinct regions of the proximal murine IL-12 p35 promoter during costimulation with IFN-gamma and LPS. Mol. Immunol. 2006. 43: 623-633.
43. Vang, K. B., Yang, J., Pagan, A. J., Li, L. X., Wang, J., Green, J. M., Beg, A. A. and Farrar, M. A., Cutting edge: CD28 and c-Rel-dependent pathways initiate regulatory T cell development. J. Immunol. 2010. 184: 4074-4077.
44. Deenick, E. K., Elford, A. R., Pellegrini, M., Hall, H., Mak, T. W. and Ohashi, P. S., c-Rel but not NF-kappaB1 is important for T regulatory cell development. Eur. J. Immunol. 2010. 40: 677-681.
45. Zheng, Y., Josefowicz, S., Chaudhry, A., Peng, X. P., Forbush, K. and Rudensky, A. Y., Role of conserved non-coding DNA elements in the Foxp3 gene in regulatory T-cell fate. Nature 2010. 463: 808-812.
46. Lopez, K. S., Dinges, S., Griewank, K., Iwakura, Y., Udey, M. C. and von Stebut, E., IL-17 promotes progression of cutaneous leishmaniasis in susceptible mice. J. Immunol. 2009. 182: 3039-3046.
47. Pitta, M. G., Romano, A., Cabantous, S., Henri, S., Hammad, A., Kouriba, B., Argiro, L. et al., IL-17 and IL-22 are associated with protection against human kala azar caused by Leishmania donovani. J. Clin. Invest. 2009. 119: 2379-2387.
48. van Zandbergen, G., Klinger, M., Mueller, A., Dannenberg, S., Gebert, A., Solbach, W. and Laskay, T., Cutting edge: neutrophil granulocyte serves as a vector for Leishmania entry into macrophages. J. Immunol. 2004. 173: 6521-6525.
49. Solbach, W., Lohoff, M., Streck, H., Rohwer, P. and Rollinghoff, M., Kinetics of cell-mediated immunity developing during the course of Leishmania major infection in 'healer' and 'non-healer' mice: progressive impairment of response to and generation of interleukin-2. Immunology 1987. 62: 485-492.
50. Brustle, A., Heink, S., Huber, M., Rosenplanter, C., Stadelmann, C., Yu, P., Arpaia, E. et al., The development of inflammatory T(H)-17 cells requires interferon-regulatory factor 4. Nat. Immunol. 2007. 8: 958-966.